Leibman Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.39M Buy
86,440
+17,433
+25% +$1.1M 3.72% 6
2026
Q2
$3.98M Buy
69,007
+2,100
+3% +$121K 2.64% 12
2026
Q1
$4.06M Buy
+66,907
New +$3.9M 2.98% 8

Other funds holding BMY

Leibman Financial Services's BMY Position: Q3 2026 in Review

Leibman Financial Services increased its Bristol-Myers Squibb (BMY) stake by 25% in Q3 2026, buying an estimated $1.1M and bringing the position to 86,440 shares worth $5.39M. The position accounts for 3.72% of the portfolio, ranked #6.

Leibman Financial Services first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 1,266 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Leibman Financial Services held 86,440 shares of Bristol-Myers Squibb worth $5.39M as of Q3 2026.
  • Leibman Financial Services bought 17,433 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.1M.
  • Bristol-Myers Squibb made up 3.72% of Leibman Financial Services's portfolio in Q3 2026, its #6 holding.
  • Leibman Financial Services first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 1,266 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Leibman Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.